2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Conbercept: new trials by email Literature Review of Conbercept trials Research Report on Conbercept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration Treat-and-Extend regimen, Pro Re Nata, Conbercept - Age-related Macular Degeneration | Phase 4 | Unknown | Xiaodong Sun | 141 | 2016-09-01 | 2020-05-19 |
| The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) Conbercept - Polypoidal Choroidal Vasculopathy (PCV) | Phase 4 | Unknown | Chengdu Kanghong Biotech Co., Ltd. | 300 | 2015-10-01 | 2017-07-19 |
Macular Degeneration (1) · Polypoidal Choroidal Vasculopathy (1)
Chengdu Kanghong Biotech Co., Ltd. (1) · Xiaodong Sun (1)
China (2)
Xiaodong Sun (1)